The Indian pharmaceutical industry is rapidly growing, with a compounded annual growth rate of over 15% and export targets set at $25 billion by 2014. The Indian Biosciences and Research Institute (IBRI) offers various regulatory affairs courses aimed at training professionals to navigate the evolving regulatory landscape in the pharmaceutical sector. The courses are designed for different levels of expertise and include comprehensive study materials, regular assessments, and support from experienced instructors.